Acquisition, Human Genome Sciences | featured news
Welcome to Wopular's coverage of Acquisition, Human Genome Sciences.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Acquisition, Human Genome Sciences that have been featured on main sections
of the site.
Below are topics about Acquisition, Human Genome Sciences. (Click on "all"
to view all articles related to the topic, including articles NOT about
Acquisition, Human Genome Sciences.
GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer.
British drugmaker GlaxoSmithKline said Wednesday it will no longer wait for Human Genome Sciences to consider an acquisition offer and instead appealed directly to the Rockville firm’s shareholders to accept its $13-per-share asking price.